About (2S,3S)-N-[(2R)-1-(4-bromopyrazol-1-yl)propan-2-yl]-2-(1-ethylimidazol-2-yl)oxolan-3-amine
(2S,3S)-N-[(2R)-1-(4-bromopyrazol-1-yl)propan-2-yl]-2-(1-ethylimidazol-2-yl)oxolan-3-amine (PubChem CID 129475592) has the molecular formula C15H22BrN5O
and a molecular weight of 368.28 g/mol. Its IUPAC name is (2S,3S)-N-[(2R)-1-(4-bromopyrazol-1-yl)propan-2-yl]-2-(1-ethylimidazol-2-yl)oxolan-3-amine.
Molecular Properties
| Compound Name | (2S,3S)-N-[(2R)-1-(4-bromopyrazol-1-yl)propan-2-yl]-2-(1-ethylimidazol-2-yl)oxolan-3-amine |
| PubChem CID | 129475592 |
| Molecular Formula | C15H22BrN5O |
| Molecular Weight | 368.28 g/mol |
| Exact Mass | 367.10 |
| IUPAC Name | (2S,3S)-N-[(2R)-1-(4-bromopyrazol-1-yl)propan-2-yl]-2-(1-ethylimidazol-2-yl)oxolan-3-amine |
| SMILES | CCn1ccnc1[C@H]1OCC[C@@H]1N[C@H](C)Cn1cc(Br)cn1 |
| InChI | InChI=1S/C15H22BrN5O/c1-3-20-6-5-17-15(20)14-13(4-7-22-14)19-11(2)9-21-10-12(16)8-18-21/h5-6,8,10-11,13-14,19H,3-4,7,9H2,1-2H3/t11-,13+,14+/m1/s1 |
| InChIKey | UVIQXRNTHMOMEG-XBFCOCLRSA-N |
| XLogP | 2.37 |
| TPSA | 56.90 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 22 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
| MW ≤ 500 | 368.28 |
| LogP ≤ 5 | 2.37 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Analyze (2S,3S)-N-[(2R)-1-(4-bromopyrazol-1-yl)propan-2-yl]-2-(1-ethylimidazol-2-yl)oxolan-3-amine with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of (2S,3S)-N-[(2R)-1-(4-bromopyrazol-1-yl)propan-2-yl]-2-(1-ethylimidazol-2-yl)oxolan-3-amine?
The IUPAC name of (2S,3S)-N-[(2R)-1-(4-bromopyrazol-1-yl)propan-2-yl]-2-(1-ethylimidazol-2-yl)oxolan-3-amine (CID 129475592) is (2S,3S)-N-[(2R)-1-(4-bromopyrazol-1-yl)propan-2-yl]-2-(1-ethylimidazol-2-yl)oxolan-3-amine.
What is the SMILES notation for (2S,3S)-N-[(2R)-1-(4-bromopyrazol-1-yl)propan-2-yl]-2-(1-ethylimidazol-2-yl)oxolan-3-amine?
The canonical SMILES for (2S,3S)-N-[(2R)-1-(4-bromopyrazol-1-yl)propan-2-yl]-2-(1-ethylimidazol-2-yl)oxolan-3-amine is CCn1ccnc1[C@H]1OCC[C@@H]1N[C@H](C)Cn1cc(Br)cn1.
What is the InChIKey of (2S,3S)-N-[(2R)-1-(4-bromopyrazol-1-yl)propan-2-yl]-2-(1-ethylimidazol-2-yl)oxolan-3-amine?
The InChIKey is UVIQXRNTHMOMEG-XBFCOCLRSA-N. The full InChI is InChI=1S/C15H22BrN5O/c1-3-20-6-5-17-15(20)14-13(4-7-22-14)19-11(2)9-21-10-12(16)8-18-21/h5-6,8,10-11,13-14,19H,3-4,7,9H2,1-2H3/t11-,13+,14+/m1/s1.
What are the key properties of (2S,3S)-N-[(2R)-1-(4-bromopyrazol-1-yl)propan-2-yl]-2-(1-ethylimidazol-2-yl)oxolan-3-amine?
(2S,3S)-N-[(2R)-1-(4-bromopyrazol-1-yl)propan-2-yl]-2-(1-ethylimidazol-2-yl)oxolan-3-amine has a molecular weight of 368.28 g/mol, XLogP of 2.37, 6 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for (2S,3S)-N-[(2R)-1-(4-bromopyrazol-1-yl)propan-2-yl]-2-(1-ethylimidazol-2-yl)oxolan-3-amine is sourced from PubChem (CID 129475592), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).